Business Wire

Loop Energy and Fraunhofer ISE Testing Demonstrates the Potential of Innovative eFlow™ Flow Field Design to Increase Hydrogen Production in Electrolyzers

6.3.2023 14:30:00 EET | Business Wire | Press release

Share

Loop Energy ™ (TSX: LPEN), a designer and manufacturer of hydrogen fuel cell solutions, has completed third-party validation of the use of its patented eFlow™ technology in PEM electrolyzers. In partnership with Fraunhofer USA, testing was conducted by the German Fraunhofer Institute for Solar Energy Systems ISE, and has demonstrated a fuel cell architecture with trapezoid flow field design can enhance temperature uniformity. When incorporated into conventional PEM electrolysis cells, this bipolar plate architecture demonstrates it can increase hydrogen production. Loop Energy is now seeking industry partners to develop a full-scale electrolyzer prototype for commercial validation.

Results show that eFlow architecture creates a more stable and uniform operating environment in the PEM water electrolysis test cells compared to conventional flow fields with parallel channels, resulting in greater hydrogen production and improved efficiency. Testing also shows the enhanced uniform operating environment should have a beneficial impact on durability.

“Results from the validation process show that the new flow field technology has the potential to surpass typical levels of hydrogen production that we see in the industry today and supports green hydrogen production to become increasingly economically viable,” said Fraunhofer ISE Head of Department Chemical Energy Storage, Dr. Tom Smolinka. “The difference we have seen from current electrolyzer performance with conventional parallel flow field is that the adapted design appears to create more uniform temperature distribution could make it an enabling technology for some of the advanced materials needed to really increase the economics of electrolyzers and green hydrogen.”

Encouraged by the results, Loop Energy and Fraunhofer ISE are inviting expressions of interest from potential industry partners. Interested parties will partner with the two companies in designing and manufacturing an electrolyzer prototype to verify eFlow’s benefits for producing hydrogen on a commercial scale. All expressions of interest can be directed to Loop Energy Chief Commercial Officer, George Rubin.

“The completion of third-party validation is an important milestone for Loop Energy as we explore how eFlow can transform the hydrogen production sector,” said Loop Energy President & CEO, Ben Nyland. “We’re extremely pleased to partner with Fraunhofer ISE and draw on their long-lasting experience in cell and stack design for PEM water electrolysis. The results have been encouraging, and we’re excited to begin the search for strategic partners to support us as we innovate electrolyzer technology.”

Currently, Loop Energy’s proprietary eFlow technology is applied in its fuel cell products to offer unmatched levels of fuel efficiency. Its tapering channel design enables eFlow to provide improved uniform current density and increases gas velocity to deliver superior thermal and water management. With the new discovery that eFlow can benefit hydrogen production efficiency, it expands the patented technology’s potential use across the hydrogen energy vertical.

Global demand for hydrogen production is projected to grow by more than US$1 trillion by 20501. As a result, both new and existing hydrogen producers are searching for a competitive advantage to meet rising demand.

Ben Nyland will share details of this development at CERAWeek on March 6 and 7 alongside Thomas Schuelke, president of Fraunhofer USA, which also acts as project partner. In addition, Dr. Tom Smolinka and Loop Energy Chief Scientist, Dr. Sean Mackinnon will present the technical results at Hannover Messe on April 17. Requests for meetings at either event can be coordinated with Ethan Hugh.

Loop Energy’s management team will share more details on its end of year financial results call on March 30. Call details can be found on Loop Energy’s website.

About Fraunhofer ISE

The Fraunhofer-Gesellschaft, based in Germany, is the world's leading organization for application-oriented research. With its focus on key technologies of relevance to the future and on the exploitation of results in business and industry, it plays a central role in the innovation process. As a guide and stimulus for innovative developments and scientific excellence, it helps shape our society and our future. Founded in 1949, the organization currently operates 76 institutes and research facilities in Germany. More than 30,000 employees, most of them trained in the natural sciences or engineering, produce the annual research volume of 2.9 billion euros. Of this, 2.5 billion euros is spent on contract research. Further information: www.ise.fraunhofer.de/en

About Fraunhofer USA

Fraunhofer USA, Inc., a legally independent US affiliate founded by Fraunhofer-Gesellschaft, is an R&D organization working with industry, universities, and state and federal governments on contract R&D projects. Fraunhofer is in the high-tech problem-solving business and utilizes world class scientific and engineering expertise to engage in complex R&D projects across many different disciplines. Through Fraunhofer USA, U.S. clients can connect to the 79 research units throughout the U.S. and Germany with over 30,000 employees, predominantly scientists and engineers. www.fraunhofer.org

About Loop Energy Inc.

Loop Energy is a leading designer and manufacturer of hydrogen fuel cell systems targeted for the electrification of commercial vehicles, including light commercial vehicles, transit buses and medium and heavy-duty trucks. Loop Energy’s products feature the company’s proprietary eFlow™ technology in the fuel cell stack’s bipolar plates. eFlow is designed to enable commercial customers to achieve performance maximization and cost minimization. Loop Energy works with OEMs and major vehicle sub-system suppliers to enable the production of hydrogen fuel cell electric vehicles. For more information about how Loop Energy is driving towards a zero-emissions future, visit www.loopenergy.com.

Forward Looking Warning

This press release contains forward-looking information within the meaning of applicable securities legislation, which reflect management’s current expectations and projections regarding future events. Particularly, statements regarding the Company’s expectations of future results, performance, achievements, prospects or opportunities or the markets in which we operate is forward-looking information, including without limitation, purchase orders, cost reduction, profitability and revenue targets; our future growth prospects and business outlook including without limitation the expected demand for our products, the allocation of resources and funds, the expected timeline for profitability, the planned growth of our customer base and the expected growth of our operations globally. Forward-looking information is based on a number of assumptions (including without limitation assumptions with respect the current and future performance of the Company’s products, growth in demand for the Company’s products, the Company’s ability to execute on its strategy, achieve its targets and progress existing and future customers through the Customer Adoption Cycle in a timely way, and is subject to a number of risks and uncertainties, many of which are beyond the Company’s control and could cause actual results and events to vary materially from those that are disclosed, or implied, by such forward-looking information.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Loop Energy Investor Inquiries:
Natalie Arseneau | Tel: +1 604.222.3400 Ext. 418 | investors@loopenergy.com

Loop Energy Business Inquiries:
George Rubin | Tel: +1.604.828.8185 | grubin@loopenergy.com

Loop Energy Media Inquiries:
Ethan Hugh | Tel: +1 604.306.4277| ethan.hugh@loopenergy.com
Lucas Schmidt | Tel: +1.778.791.8756 | lucas.schmidt@loopenergy.com

Fraunhofer ISE Inquiries:
Dr. Tom Smolinka | Tel: +49.761.4588.5212 | tom.smolinka@ise.fraunhofer.de
Diana Bribach | Tel: +49.761.4588.2804 | diana.bribach@ise.fraunhofer.de

Fraunhofer USA Inquiries:
Elliott Sprehe | Tel: +734.927.3984 | esprehe@fraunhofer.org

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Final MINT Study Results Strengthen Real-World Evidence for Mogamulizumab (Poteligeo ® ) in Patients With Mycosis Fungoides and Sézary Syndrome12.10.2026 09:00:00 EEST | Press release

Kyowa Kirin International plc, a wholly owned subsidiary of Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), today announced final results from the German MINT study evaluating mogamulizumab in patients with mycosis fungoides (MF) and Sézary Syndrome (SS). Presented at the European Organisation for Research and Treatment of Cancer Cutaneous Lymphoma Tumour Group (EORTC-CLTG) Annual Meeting 2026 in Berlin, Germany, the findings represent one of the largest real-world evaluations of mogamulizumab in Germany and add to the growing body of evidence supporting its use in routine clinical practice.1-3 Conducted as a company-sponsored, multicentric, non-interventional, combined retro-prospective real-world study across 18 centres throughout Germany, MINT brought together cutaneous T‑cell lymphoma (CTCL) specialists to evaluate treatment outcomes with mogamulizumab in a real-world setting, with time-to-next-treatment (TTNT) as the study’s primary endpoint.1 The study captured a broad and heterog

Megaport Expands Global Automated Infrastructure Platform Into Portugal12.10.2026 09:00:00 EEST | Press release

Megaport Limited (ASX: MP1) (“Megaport”), a leading global automated infrastructure platform, today announced the launch of its services in Portugal, expanding its European footprint and enabling enterprises and service providers in the region to connect instantly to the world’s leading cloud, network, and data center providers. With new on-ramps in Lisbon, customers in Portugal can now access Megaport’s automated infrastructure platform as well as more than 1,200 enabled data centers worldwide. This launch gives enterprises, MSPs, and carriers private, high-performance compute, network, and storage, as well as on-demand regional interconnection with scalable bandwidth. With Portugal’s data center market projected to reach US$3.09 billion by 2030 as well as Lisbon’s proximity to major submarine cable landings, the strengthening global connectivity hub is a natural next step for Megaport. “Portugal’s digital economy is rapidly growing, and infrastructure is at the heart of that transfor

Filippo Fagnani from Quanta System Receives the EAU Award for Significant Contribution to Endourology at ICE 202610.10.2026 19:09:00 EEST | Press release

Filippo Fagnani, Marketing & Scientific Director of Quanta System’s Surgical Division, has been honoured with the Award for Significant Contribution to Endourology at ICE26, the International Conference on Endourology organised by the EAU Endourology Section. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261010101303/en/ Filippo Fagnani receiving the prize with Olivier Traxer and Professor Bhaskar Somani. The recognition celebrates more than two decades of professional commitment to laser technology and a career built around a clear ambition: to translate the needs of urologists into increasingly precise, flexible and useful technologies, with the ultimate goal of supporting patient safety and better surgical outcomes. “I have always believed that technology should make the surgeon’s work more precise, more flexible and, most importantly, safer for the patient. My goal has never been to develop technology for its own sake,

Emdoor Information Marks 18 Years of Rugged Computing Excellence with Vertically Integrated Capabilities10.10.2026 13:30:00 EEST | Press release

As industrial automation, smart manufacturing, and field operations increasingly depend on mission-critical mobile computing, global demand for reliable rugged tablets, rugged laptops, and rugged handhelds continues to accelerate. Emdoor Information, a publicly listed company on China’s A-share main board since 2023 and an 18-year veteran in rugged computing, has established itself as a rugged computing solutions provider for industrial customers worldwide. Founded in 2008, the company delivers sustained growth, world-class manufacturing, resilient supply chains, full-stack R&D, and comprehensive lifecycle services. Its rugged computing products and industrial customers now span North America, Latin America, Europe, and Asia-Pacific, serving sectors such as public utilities, intelligent manufacturing, warehouse management, transportation, energy industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261010564561/en/ Rugged

Vertex to Present New Data on ALYFTREK ® at the North American Cystic Fibrosis Conference9.10.2026 20:15:00 EEST | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced new interim data from the ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor) 2 to 5 years old open-label extension study, highlighting recovery of exocrine pancreatic function in some children in that age group, allowing those children to discontinue pancreatic enzyme replacement therapy (PERT). Pancreatic exocrine insufficiency in children with cystic fibrosis (CF) was previously believed to be irreversible. These data were presented at the North American Cystic Fibrosis Conference (NACFC). “The data presented at NACFC underscore the safety and efficacy of our CF medicines in the real world and in clinical trials in younger age groups. The data from the Phase 3 open-label study in 2 to 5 year olds evaluating exocrine pancreatic function represent a profound shift in how we understand the benefits of treating cystic fibrosis in its earliest stages,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Devel

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye